Typical Patient Presentation

Slides:



Advertisements
Similar presentations
The Late Sodium Current in the cardiac myocite: How viable as a new therapeutic target in angina? SPONSORED SATELLITE SESSION Dr Stephen Holmberg Lead.
Advertisements

MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Many alternatives for treating ischemia and angina: how to choose?
Ranolazine The mechanism of action of ranolazine has not been determined, but it may be related to reduction in calcium overload in ischemic myocytes.
Diabetic Dyslipidemia in Practice
Deciphering Obesity Management Guidelines
The Effect of Intra-Articular Steroids on Cartilage in Knee Osteoarthritis.
New Guidelines to Prevent SCD: What You Need to Know
NOACs for Cancer-Associated Thrombosis:
Diabetes and Risk of CV Outcomes
Atrial Fibrillation and PCI
The Role of Anticholinergic Therapy in Moderate to Severe Asthma
Getting the 411 on TAVR Trials
SIHD Guidelines. Personalized Medicine: Applying Guidelines to the Individual Patient With SIHD.
Emerging Data on ACS Management From ACC
Applying New Data in Practice:
Dual Goals for the Management of Stable Ischemic Heart Disease (SIHD)
Patient Case Discussions in T2D: What Intensification Plan Is Best?
Novel Developments & Latest Clinical Results With Long-Acting GLP-1 Receptor Agonists.
Early Type 2 Diabetes Mellitus: A Cardiovascular Disease
How and When to Decide on Revascularization in Stable Ischemic Heart Disease.
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Recurrent Angina: New Tools for an Old Problem
Clarifying Optimal Patient Selection for Long-Term DAPT Post-MI
Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.
Statins and New-Onset Diabetes REAL Updates and Clinical Implications
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
UKPDS 34: Metformin vs Conventional Glycemic Control on Outcomes
Selected Causes of Cardiac Injury PEACE Trial High-Sensitivity Biomarker Substudy.
Selected Highlights of the Latest Advances in PAH
Antithrombotic Protection in CAD and HF
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
A Hard Look at Cardiogenic Shock: IABP-SHOCK II Revisited
Reversal Strategies for VKA: Truths and Misconceptions
Oral Anticoagulation in AF
Mitral Valve Disease.
New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.
Panelists. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?
Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.
Treating to Target in MS
Using Heart Rate as a Biomarker in Clinical Practice.
GLP-1 Receptor Agonists: A Tool for the Primary Care Physician to Reduce CV Risk in Diabetes?
Learning Objectives Metabolic Abnormalities Associated With T2D.
The Cardiologist's Mindset in the Management of Diabetes and Coronary Artery Disease: Today and Tomorrow.
Aspirin and Cardioprevention in 2018
Identifying High-Risk AF Patients
Challenging the Myths in Heart Failure With Reduced Ejection Fraction
The Road to Quality Improvement in HER2-Positive Breast Cancer
Factor Xa Inhibitors in PAD
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Case Challenges: Early and Intensive Type 2 Diabetes Treatment With Modern Agents.
Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.
Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.
Pharmacotherapy for Diabetic Coronary Disease:
New ELN Recommendations
Antithrombotic Therapy in Vascular Protection: From CAD to HF
Add-On Therapy to Insulin in T1DM Management
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes
Factor Xa Inhibitors in Coronary Artery Disease
Practical Strategies for Getting Patients With Diabetes to Lipid Goal
My PAH Patient.
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
Top Tips in Evidence-Based Care for HFrEF
Expert Perspectives.
NAFLD and NASH in Europe and Canada
The Power of As-Treated Analyses
The Challenge of Insulin Titration
Translating Data From Trial to Practice
Presentation transcript:

Typical Patient Presentation

Diabetes and Angina The Misconceptions

Frequently Used Antianginals Long-term Outcomes

Newer Antianginals Ranolazine

Early Ranolazine Trials

MERLIN Trial

MERLIN Results

MERLIN Glycemic and Antianginal Effects

TERISA Trial

TERISA Resultsa and Implications

Current Guidelines Long-term Prognosis in ACS

Current Guidelines Stable Ischemic Heart Disease

Future Directions

Conclusions

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.